Publications by authors named "Vera Todisco"
Article Synopsis
- Patients with hematological malignancies are at a higher risk for severe COVID-19 during the Omicron variant's prevalence, with significant health impacts observed in those with negative SARS-CoV2 serology.
- A study of 112 patients revealed that seronegative individuals were older, more likely to have certain types of cancer, and faced worse health outcomes, including higher rates of respiratory failure, mechanical ventilation, and COVID-related death.
- The findings suggest that negative SARS-CoV2 serology can serve as a useful indicator to identify patients at increased risk for severe complications from COVID-19, highlighting the importance of serology testing in managing these patients.
Background: We aimed to describe prevalence, incidence, and risk factors for sarcopenic obesity (SO) phenotypes in people living with HIV (PWH) and their association with subclinical cardiovascular disease (CVD).
Methods: Observational, longitudinal study of PWH. A minimum of 1 criterion was necessary to diagnose sarcopenia: weak hand grip (HG), low appendicular skeletal muscle index (ASMI), short physical performance battery (SPPB < 11).
Purpose: People with hematologic malignancies have a significantly higher risk of developing severe and protracted forms of SARS-CoV-2 infection compared to immunocompetent patients, regardless of vaccination status.
Results: We describe two cases of prolonged SARS-CoV-2 infection with multiple relapses of COVID-19 pneumonia in patients with follicular lymphoma treated with bendamustine and obinutuzumab or rituximab. The aim is to highlight the complexity of SARS-CoV-2 infection in this fragile group of patients and the necessity of evidence-based strategies to treat them properly.